Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-26
DOI
10.3389/fimmu.2019.01440
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psoriasis: from Pathogenesis to Targeted Therapies
- (2018) Curdin Conrad et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation
- (2018) Miao Xu et al. IMMUNITY
- Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches
- (2018) Pooja Todke et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis
- (2018) Lea Shallev et al. RNA
- Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation
- (2018) Hui Li et al. Nature Communications
- TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
- (2018) Curdin Conrad et al. Nature Communications
- Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors
- (2018) Toshiya Takahashi et al. Scientific Reports
- The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
- (2018) Cristina Albanesi et al. Frontiers in Immunology
- Type I Interferons in Autoimmune Disease
- (2018) Mary K. Crow et al. Annual Review of Pathology-Mechanisms of Disease
- Relative versus absolute risk of comorbidities in patients with psoriasis
- (2017) Mohammed D. Saleem et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Early relapse of psoriasis after stopping brodalumab: a retrospective cohort study in 77 patients
- (2017) M. Masson Regnault et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Rebound pustular psoriasis after brodalumab discontinuation
- (2016) A. Khemis et al. BRITISH JOURNAL OF DERMATOLOGY
- A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury
- (2016) Ling-juan Zhang et al. IMMUNITY
- Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin Inflammation
- (2016) Jun Gui et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secukinumab withdrawal leads to loss of treatment responses in a majority of subjects with plaque psoriasis with retreatment resulting in rapid regain of responses: A pooled analysis of two phase 3 trials
- (2016) JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Beyond pan-B-cell-directed therapy — new avenues and insights into the pathogenesis of SLE
- (2016) Thomas Dörner et al. Nature Reviews Rheumatology
- Comorbidities of Psoriasis - Exploring the Links by Network Approach
- (2016) Sudharsana Sundarrajan et al. PLoS One
- dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration
- (2015) Amanda M. Nelson et al. Cell Stem Cell
- An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
- (2015) Lynda Grine et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility
- (2015) Xianyong Yin et al. Nature Communications
- GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region
- (2014) D L Armstrong et al. GENES AND IMMUNITY
- Microarray Analyses Demonstrate the Involvement of Type I Interferons in Psoriasiform Pathology Development in D6-deficient Mice
- (2013) Helen M. Baldwin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
- (2013) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
- (2013) Michelle A. Lowes et al. TRENDS IN IMMUNOLOGY
- The Role of Type 1 Interferon in Systemic Sclerosis
- (2013) Minghua Wu et al. Frontiers in Immunology
- Type I interferons in Sjögren's syndrome
- (2012) Yihong Yao et al. AUTOIMMUNITY REVIEWS
- Ctip2 is a dynamic regulator of epidermal proliferation and differentiation by integrating EGFR and Notch signaling
- (2012) L.-j. Zhang et al. JOURNAL OF CELL SCIENCE
- IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis
- (2012) Mikiko Tohyama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis during natalizumab treatment for multiple sclerosis
- (2012) Jorge Millán-Pascual et al. JOURNAL OF NEUROLOGY
- Ultraviolet radiation damages self noncoding RNA and is detected by TLR3
- (2012) Jamie J Bernard et al. NATURE MEDICINE
- Selective Ablation of Ctip2/Bcl11b in Epidermal Keratinocytes Triggers Atopic Dermatitis-Like Skin Inflammatory Responses in Adult Mice
- (2012) Zhixing Wang et al. PLoS One
- Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis
- (2011) Marie-José Bijlmakers et al. HUMAN MOLECULAR GENETICS
- Type I interferon pathway in adult and juvenile dermatomyositis
- (2011) Emily C Baechler et al. ARTHRITIS RESEARCH & THERAPY
- Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
- (2010) Josh Gregorio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon: friend or foe?
- (2010) Giorgio Trinchieri JOURNAL OF EXPERIMENTAL MEDICINE
- Keratinocyte but Not Endothelial Cell-Specific Overexpression of Tie2 Leads to the Development of Psoriasis
- (2009) Julie A. Wolfram et al. AMERICAN JOURNAL OF PATHOLOGY
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Commensal bacteria regulate Toll-like receptor 3–dependent inflammation after skin injury
- (2009) Yuping Lai et al. NATURE MEDICINE
- Psoriasis during interferon beta treatment for multiple sclerosis
- (2009) Loredana La Mantia et al. NEUROLOGICAL SCIENCES
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD300a/c regulate type I interferon and TNF- secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands
- (2008) X. Ju et al. BLOOD
- From conventional to cutting edge: the new era of biologics in treatment of psoriasis
- (2008) Julia Tzu et al. Dermatologic Therapy
- Type I Interferon: Potential Therapeutic Target for Psoriasis?
- (2008) Yihong Yao et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started